Company Profile
Anhui Anke Biotechnology (Group) provides the biopharmaceutical industry in China and globally. It offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection Recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name.
The company provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, immunohistochemical, sperm DNA fragmentation staining, leptin, and immunohistochemical diagnostic kits
Adhesive plasters, oral solutions, topical preparations, and ointments. Its portfolio also includes peptide APIs, beauty care products including anti-aging, masks, essential liquids, and mouthwash, and sybthetic drugs in the form of oral powders, dripping pills, and tablets and capsules.
It also provides autosomal, sex chromosome, and kits; paternity testing, tumor biological immunotherapy technology, and DNA testing services Monoclonal antibody drugs, such as Trastuzumab to treat patients with breast and gastric cancers under the ANTRASTUIN brand. Its portfolio also includes Bevacizumab, an anti-VFDF product, ANKEBIO anti-PD1, and anti-covid19 products. Founded in 2000, the company is based in Hefei, China.